VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

11293	Companies
250967	Keywords
179878	Articles
136836	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 03/23/2026 at 12:17, 7 months 15 days ago

Pfizer et Valneva annoncent que le candidat vaccin contre la maladie de Lyme démontre une forte efficacité dans l’essai de Phase 3 VALOR
Pfizer et Valneva ont démontré l'efficacité de plus de 70 % de leur candidat vaccin contre la maladie de Lyme dans l'essai de Phase 3 VALOR. Pfizer prévoit de déposer des dossiers réglementaires

Efficacité Valneva Maladie De Lyme Pfizer Vaccin
BRIEF

published on 02/20/2026 at 12:01, 8 months 15 days ago

Valneva SE: Research Update and Financial Projections

Valneva SE Financial Update Lyme Vaccine Third-Party Sales Target Price Adjustments
BRIEF

published on 02/20/2026 at 12:01, 8 months 15 days ago

Valneva SE : Mise à jour de la recherche et projections financières

Valneva SE Mise À Jour Financière Vaccin Contre La Maladie De Lyme Ventes Par Des Tiers Ajustements Du Prix Cible
PRESS RELEASE

published on 02/20/2026 at 11:56, 8 months 15 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updated Valneva SE's classification to Buy with a target price of €6.60. Details on 2025 revenues, cash figures, and 2026 guidance included

Buy Recommendation Valneva SE First Berlin Equity Research GmbH 2025 Revenues 2026 Guidance
BRIEF

published on 01/09/2026 at 07:05, 9 months 29 days ago

Valneva Engages Investors at J.P. Morgan Healthcare Conference

Valneva Investor Meetings Lyme Disease Vaccine J.P. Morgan Conference Vaccine Portfolio
BRIEF

published on 01/09/2026 at 07:05, 9 months 29 days ago

Valneva s'adresse aux investisseurs lors de la conférence JP Morgan sur les soins de santé

Valneva Vaccin Contre La Maladie De Lyme Réunions Avec Les Investisseurs Conférence JP Morgan Portefeuille De Vaccins
PRESS RELEASE

published on 01/09/2026 at 07:00, 9 months 29 days ago

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
Valneva SE to meet with investors at the J.P. Morgan Healthcare Conference to discuss upcoming catalysts from its clinical development pipeline and commercial portfolio of vaccines. Company specializes in prophylactic vaccines for infectious diseases

Valneva SE Prophylactic Vaccines J.P. Morgan Healthcare Conference Vaccine Company Clinical Development Pipeline
PRESS RELEASE

published on 01/09/2026 at 07:00, 9 months 29 days ago

Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
Valneva SE rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference à San Francisco pour discuter des avancées de son portefeuille de vaccins et des résultats attendus pour le vaccin contre la maladie de Lyme

Investisseurs Valneva SE Maladie De Lyme Vaccins J.P. Morgan Healthcare Conference
BRIEF

published on 12/31/2025 at 17:50, 10 months 6 days ago

Valneva et le Serum Institute mettent fin à leur collaboration sur le vaccin contre le chikungunya

Valneva Santé Publique Contrat De Licence Vaccin Contre Le Chikungunya Institut Du Sérum
BRIEF

published on 12/31/2025 at 17:50, 10 months 6 days ago

Valneva and Serum Institute End Chikungunya Vaccine Collaboration

Public Health Valneva License Agreement Chikungunya Vaccine Serum Institute

Accesswire

Published on 11/06/2026 at 22:15, 18 hours 14 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 3 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 3 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 3 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day 6 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/07/2026 at 13:35, 2 hours 54 minutes ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 20 hours 14 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 20 hours 14 minutes ago

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 21 hours 14 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 21 hours 29 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet

Les Echos

Published on 11/06/2026 at 19:06, 21 hours 23 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 21 hours 25 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 21 hours 27 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 21 hours 29 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 22 hours 29 minutes ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE